These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1638024)

  • 21. Soluble CD56 (NCAM): a new differential-diagnostic and prognostic marker in multiple myeloma.
    Kaiser U; Oldenburg M; Jaques G; Auerbach B; Havemann K
    Ann Hematol; 1996 Sep; 73(3):121-6. PubMed ID: 8841099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of serum beta 2-microglobulin as a prognostic indicator in myelomatosis.
    Child JA; Crawford SM; Norfolk DR; O'Quigley J; Scarffe JH; Struthers LP
    Br J Cancer; 1983 Jan; 47(1):111-4. PubMed ID: 6185132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma. Finnish Leukaemia Group.
    Pulkki K; Pelliniemi TT; Rajamäki A; Tienhaara A; Laakso M; Lahtinen R
    Br J Haematol; 1996 Feb; 92(2):370-4. PubMed ID: 8603002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment serum beta 2-microglobulin in multiple myeloma.
    Brenning G; Simonsson B; Källander C; Ahre A
    Br J Haematol; 1986 Jan; 62(1):85-93. PubMed ID: 3510657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A plea to overcome the concept of "staging" and related inadequacy in multiple myeloma.
    Gobbi PG; Bertoloni D; Grignani G; Pieresca C; Rossi A; Rutigliano L; Merlini G; Riccardi A; Ascari E
    Eur J Haematol; 1991 Mar; 46(3):177-81. PubMed ID: 2009950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new staging system for multiple myeloma based on the number of S-phase plasma cells.
    San Miguel JF; García-Sanz R; González M; Moro MJ; Hernández JM; Ortega F; Borrego D; Carnero M; Casanova F; Jiménez R
    Blood; 1995 Jan; 85(2):448-55. PubMed ID: 7811998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity.
    Alexandrakis MG; Passam FH; Sfiridaki A; Kandidaki E; Roussou P; Kyriakou DS
    Am J Hematol; 2003 Apr; 72(4):229-33. PubMed ID: 12666132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum beta 2-microglobulin at remission and relapse in patients with multiple myeloma.
    Brenning G; Wibell L; Bergström R
    Eur J Clin Invest; 1985 Oct; 15(5):242-7. PubMed ID: 3935453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum beta 2-microglobulin levels in multiple myeloma and monoclonal gammapathy of undetermined significance: a clinical study of 55 patients.
    Chelazzi G; Senaldi G
    Ric Clin Lab; 1986; 16(1):53-8. PubMed ID: 3090677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The prognostic significance of the beta 2-microglobulin level of the blood serum in multiple myeloma patients].
    Lubo-Lesnichenko IF; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MN; Stel'mashenko LV
    Ter Arkh; 1996; 68(10):28-31. PubMed ID: 9026938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stratification of multiple myeloma according to serum beta 2-microglobulin and serum albumin levels.
    Scudla V; Budíková M; Fischerová E; Zadrazil J; Indrák K
    Acta Univ Palacki Olomuc Fac Med; 1991; 130():201-12. PubMed ID: 1838869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute phase proteins and prognosis in multiple myeloma.
    Merlini G; Perfetti V; Gobbi PG; Quaglini S; Franciotta DM; Marinone G; Ascari E
    Br J Haematol; 1993 Apr; 83(4):595-601. PubMed ID: 7686034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of myeloma cells by means of labeling index, bone marrow histology, and serum beta 2-microglobulin.
    Schambeck CM; Bartl R; Höchtlen-Vollmar W; Wick M; Lamerz R; Fateh-Moghadam A
    Am J Clin Pathol; 1996 Jul; 106(1):64-8. PubMed ID: 8701935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum beta 2 microglobulin in multiple myeloma and related plasma cell dyscrasias.
    Pasquini E; Tiraferri E; Fattori PP; Fabbri I; Gobbi M
    Haematologica; 1987; 72(1):17-21. PubMed ID: 3108090
    [No Abstract]   [Full Text] [Related]  

  • 35. [Value of the determination of beta-2-microglobulin in the monitoring of myeloma. Apropos of 290 determinations].
    Kaltwasser P; Sauger F; Le Loet X; Pasquis P; Monconduit M; Deshayes P
    Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):359-63. PubMed ID: 6179150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of pretreatment serum beta 2-microglobulin levels in multiple myeloma.
    Scarffe JH; Anderson H; Palmer MK; Crowther D
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1361-4. PubMed ID: 6357802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum beta 2-microglobulin: a real improvement in the management of multiple myeloma?
    van Dobbenburgh OA; Rodenhuis S; Ockhuizen T; Weltevreden E; Houwen B; Fidler V; Meijer S; Marrink J
    Br J Haematol; 1985 Dec; 61(4):611-20. PubMed ID: 3910076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. International staging system for multiple myeloma.
    Greipp PR; San Miguel J; Durie BG; Crowley JJ; Barlogie B; Bladé J; Boccadoro M; Child JA; Avet-Loiseau H; Kyle RA; Lahuerta JJ; Ludwig H; Morgan G; Powles R; Shimizu K; Shustik C; Sonneveld P; Tosi P; Turesson I; Westin J
    J Clin Oncol; 2005 May; 23(15):3412-20. PubMed ID: 15809451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum beta 2-microglobulin in patients with monoclonal gammopathies.
    Di Giovanni S; Valentini G; Ravazzolo E; Carducci P; Giallonardo P; Maschio C
    Int J Biol Markers; 1987; 2(3):169-72. PubMed ID: 3131451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma.
    Alexandrakis MG; Passam FH; Ganotakis ES; Sfiridaki K; Xilouri I; Perisinakis K; Kyriakou DS
    Clin Lab Haematol; 2003 Feb; 25(1):41-6. PubMed ID: 12542441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.